FOLH1 and posterior cortical atrophy: The recent introduction of positron emission tomography associated with computed tomography (PET/CT) using a radioligand of PSMA for PCa imaging has had an impact on the therapeutic management of PCa patient with biochemical recurrence (BCR)6–8, but its interest in restaging CRPC patients is unclear.